Plus therapeutics initiates cohort 3 in phase 1/part a of the respect-lm trial for leptomeningeal metastases

First data readout of phase 1/part a trial expected second half of 2023 first data readout of phase 1/part a trial expected second half of 2023
pstv Ratings Summary
pstv Quant Ranking